| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tvardi Therapeutics, Inc. (TVRD) has 5 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. TVRD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 47.5K | $198.6K | - | |
| Other | 17.5K | $73.2K | - | |
| CFO | 17.5K | $73.2K | - | |
| Other | 4.0K | $16.7K | - | |
| 10% | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2015 | Stauffer Joseph William | Chief Medical Officer | Buy | 2,000 | $18.60 | $37,200.00 | +17.5% | |
| Aug 3, 2015 | Menzaghi Frederique Ph.d.85 | Vp-research &Development | Sell | 7,000 | $21.41 | $149,870.00 | -4.0% | |
| Jul 1, 2015 | Menzaghi Frederique Ph.d.85 | Vp-research &Development | Sell | 7,000 | $12.22 | $85,540.00 | -3.9% | |
| Jul 1, 2015 | Lewis Michael E | Chief Scientific Advisor | Sell | 7,262 | $11.66 | $84,674.92 | -2.2% | |
| Jun 1, 2015 | Lewis Michael E | Chief Scientific Advisor | Sell | 7,262 | $9.50 | $68,989.00 | -2.2% | |
| May 19, 2015 | Slagel Dean | Director | Sell | 188,811 | $10.02 | $1,891,427.80 | -4.3% | |
| May 1, 2015 | Lewis Michael E | Chief Scientific Advisor | Sell | 7,262 | $10.64 | $77,267.68 | -2.1% | |
| Apr 1, 2015 | Lewis Michael E | Chief Scientific Advisor | Sell | 7,262 | $9.90 | $71,893.80 | -2.1% | |
| Mar 2, 2015 | Lewis Michael E | Chief Scientific Advisor | Sell | 7,262 | $10.11 | $73,418.82 | -2.0% | |
| Feb 17, 2015 | Schoell Josef | Chief Financial Officer | Sell | 15,000 | $10.96 | $164,400.00 | -37.5% |